The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words "paralyzing agent" on the vial caps of two neuromuscular blocking agents: ...

Perioperative anaphylaxis due to neuromuscular blocking agents occurred in roughly 58 per 100,000 administrations, with nearly 20% of cases associated with morbidity. Most patients recovered fully, ...

Researchers have found that the use of intermediate-acting neuromuscular blocking agents is linked with postoperative respiratory problems, according to a study reported in Anesthesiology News. The ...

Under anesthesia, patients are often given muscle-relaxing neuromuscular blockers to make intubations easier and reduce the skeletal muscle tone during surgery. Using a drug to remove the blocking ...

Neuromuscular blocking agents, or muscle relaxants, are often used in surgery to prevent muscles from moving when a patient is unconscious. A recent study found that the use of neuromuscular blockers ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Qualitative study involving in-depth interviews with 10 Dutch pediatricians working with severely ill neonates. Data were analyzed using appropriate qualitative research techniques. These criteria of ...

Drugs used for ventilator patients—such as sedatives and neuromuscular blockers—are running low. Healthcare performance company Vizient identified looming potential shortages among 13 drugs (PDF) ...

Vecuronium Bromide, a neuromuscular blocker, is indicated as adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ...

Under anesthesia, patients are often given muscle-relaxing neuromuscular blockers to make intubations easier and reduce the skeletal muscle tone during surgery. Using a drug to remove the blocking ...